At the news
? NEUTRALIMPACT 3/10 8-K filed May 26, 2026 at 08:00 ET
CG Oncology announced the departure of President & COO Ambaw Bellete, effective June 30, 2026, and appointed CEO Arthur Kuan as President in addition to his existing roles. The company has initiated a search for a Chief Commercial Officer. This is a routine executive reorganization with no material financial impact.
- President & COO Ambaw Bellete agreed to separation effective June 30, 2026
- CEO Arthur Kuan appointed as President in addition to his current positions
- Company initiated search for a Chief Commercial Officer
- Bellete will receive severance benefits per existing employment agreement
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access